RP1
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1. (NCT05858229) | Sherrif Ibrahim | 2023-06-16 |
Track RP1 automatically
Every clearance here is in the API, with alerts when new ones post.